Company
Phormed
Restoring hope for patients battling cancer, neurological and lung disorders
Also known as PhorMed, Inc
- Status
- Operatingas of 2026-09-19Source (opens in a new tab)
- Business model
- B2B
- Legal name
- PhorMed, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
We are a biopharmaceutical company focused on the development and commercialization of RLC/929, a targeted, cell repair, immunotherapy, that promotes the reduction of inflammation for treating neurological diseases, cancer, and such inflammatory lung disorders as Acute Respiratory Distress Syndrome (ARDS).
Funding snapshot
- Latest round
- Reg cf crowdfunding2024-02-22
Funding rounds
- Reg cf crowdfunding
- 2024-02-22
Products
- Other
- RLC/929
Loading relationship preview